Co-Dergocrine Mesylate
- 1 January 1992
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 2 (3) , 153-173
- https://doi.org/10.2165/00002512-199202030-00002
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- CorrespondenceJournal of Geriatric Psychiatry and Neurology, 1991
- PiracetamDrugs & Aging, 1991
- Topographic brain mapping of EEG after acute application of ergotalkaloids in the elderlyArchives of Gerontology and Geriatrics, 1990
- Effect of long term hydergine treatment on the age-dependent loss of mossy fibers and of granule cells in the rat hippocampusArchives of Gerontology and Geriatrics, 1990
- Effects of prolonged co-dergocrine mesylate (Hydergine®) treatment on local cerebral glucose uptake in aged Fischer 344 ratsArchives of Gerontology and Geriatrics, 1986
- Some Correlations in Geriatric Patients between EEG Parameters and Clinical Status as Evaluated Using the Observer-Rated SCAG Rating ScaleNeuropsychobiology, 1986
- Alzheimer??s Disease Is It Worth Treating?Drugs, 1985
- ???Cerebroactive??? Drugs Clinical Pharmacology and Therapeutic Role in Cerebrovascular DisordersDrugs, 1983
- The Effects of an Ergot Alkaloid Derivative (Hydergine) on Aspects of Psychomotor Performance, Arousal, and Cognitive Processing AbilityThe Journal of Clinical Pharmacology, 1979
- Ergot alkaloids: Hepatic distribution and estimation of absorption by measurement of total radioactivity in bile and urineJournal of Pharmacokinetics and Biopharmaceutics, 1976